EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR ‐766‐3p Inhibit the Proliferation, Stemness, and Cell Cycle of Pancreatic Cancer Cells Through the MAPK / ERK Signaling Pathway

Zhipeng Quan iD, Ziwei Yin, Yuelin Huang, Xuemei Huang, Hao Huang, Qingrong Mo, Jianhua Gong, Lingyun Liu, Yi Zhou, Yaqun Yu

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.70049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Zhipeng Quan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms, Cell Proliferation, MAP Kinase Signaling System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Provincial Natural Science Foundation, Guangxi Natural Science Foundation, Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As a commonly identified cancer in clinics, pancreatic cancer (PC) has poor prognostic outcomes. This work focused on clarifying the association between MIR‐766‐3P expression and PC development and progression, as well as the possible role as a biomarker in PC.

Methods

MIR‐766‐3P expression within the human PC cells and samples was measured through miRNA RT‐PCR. The gene levels regulated by MIR‐766‐3P were analyzed through western blot (WB) and qRT‐PCR. To analyze whether MIR‐766‐3P was of certain significance in in vitro and in vivo PC cell proliferation, stemness, and cell cycle progression, the gain/loss‐of‐function assays were performed. Bioinformatics, RNA sequencing (RNA‐seq), and luciferase reporter assay were conducted for exploring regulatory role of MIR‐766‐3P / MAPK1 / MAPK/ERK signal axis in PC.

Result

In comparison with the normal controls, MIR‐766‐3P expression markedly decreased the tissues and cells of PC. Furthermore, MIR‐766‐3P could remarkably inhibit the proliferation, stemness, cell cycle progression, and development of PC. The analyses using RNA‐seq, and dual‐luciferase examination showed that MIR‐766‐3P could directly target mitogen‐activated protein kinase 1 ( MAPK1 ). According to Gene Ontology (GO) as well as Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, MIR‐766‐3P could affect PC malignant phenotype by MAPK1 and the regulation of the MAPK/ERK ‐related pathway.

Conclusion

MIR‐766‐3P has a certain impact on PC malignant phenotype through combining with MAPK1 while regulating MAPK/ERK ‐related pathway in vitro and in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPancreatic NeoplasmsCell ProliferationMAP Kinase Signaling SystemNeoplastic Stem CellsHumansAnimalsCell Line, TumorMiceCell CycleGene Expression Regulation, NeoplasticMice, NudeMitogen-Activated Protein Kinase 1Mice, Inbred BALB C

Stichwörter der Autor:innen

MAPK/ERKMAPK1MIR‐766‐3Ppancreatic cancer

Substanzen

MicroRNAsMIRN766 microRNA, humanMitogen-Activated Protein Kinase 1MAPK1 protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, Guangxi, China.
  • Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, China.
  • Health Management Center, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First College of Clinical Medical Science (China Three Gorges University), Yichang, China.

ORCID-Profile: Zhipeng Quan

Förderung

  • Guangxi Provincial Natural Science Foundation
  • Guangxi Natural Science Foundation
  • Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair
  • The Self‑Funded Scientific Research Project of Guangxi Zhuang Autonomous Region Health Commission
  • The National Natural Science Foundation of China
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor(Guangxi Medical University), Ministry of Education/Guangxi Key Laboratory of…
  • The Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department
  • Yichang medical and health science and technology project

Zitieren

APA

Quan, Z., Yin, Z., Huang, Y., Huang, X., Huang, H., Mo, Q., Gong, J., Liu, L., Zhou, Y., & Yu, Y. (2024). MiR ‐766‐3p Inhibit the Proliferation, Stemness, and Cell Cycle of Pancreatic Cancer Cells Through the MAPK / ERK Signaling Pathway. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70049

Vancouver

Quan Z, Yin Z, Huang Y, Huang X, Huang H, Mo Q, et al. MiR ‐766‐3p Inhibit the Proliferation, Stemness, and Cell Cycle of Pancreatic Cancer Cells Through the MAPK / ERK Signaling Pathway. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.70049

BibTeX
@article{Quan2024,
  author = {Quan, Zhipeng and Yin, Ziwei and Huang, Yuelin and Huang, Xuemei and Huang, Hao and Mo, Qingrong and Gong, Jianhua and Liu, Lingyun and Zhou, Yi and Yu, Yaqun},
  title = {MiR ‐766‐3p Inhibit the Proliferation, Stemness, and Cell Cycle of Pancreatic Cancer Cells Through the MAPK / ERK Signaling Pathway},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.70049}
}
Kostenlos starten →